Abstract
One of the most common mental conditions and a major contributor to disability is anxiety disorders. While a great deal of research is still being done on depression, schizophrenia, and posttraumatic stress disorder (PTSD), there aren't many new drugs being studied for anxiety disorders. Anxiety is an extreme fear-based biological warning system that gets us ready to take action. It has to be distinguished from the typical terror reaction. Among the most prevalent mental illnesses among children and teenagers, anxiety disorders frequently go undiagnosed or untreated. A variety of characteristics, such as race, sex, the kind of anxiety, and the quality of epidemiological research influences a community's anxiety prevalence. Treatments such as transcranial magnetic stimulation, medication augmentation, and novel pharmaceutical agents like vortioxetine showed mixed results when used to individuals with anxiety disorders who did not respond well to conventional therapies or only partially responded to it. The public should only be offered new anxiety disorder treatment alternatives following a careful assessment of their effectiveness. Integrative teamwork and the management of anxiety disorders in need include cognitive behavioral therapy, mindfulness-based psychotherapies, psychodynamic psychotherapies, and psychopharmacologic treatments.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
